Allergan [clinicaltrials_resource:80124512cb2eba14e3f43e0326e728c2]
Medical Director [clinicaltrials_resource:1c9ef8d956a869a19dc76ae87aee8189]Allergan Inc. [clinicaltrials_resource:1e6df70b9d3a96cb39da7fdcb9a52473]Medical Director [clinicaltrials_resource:2b9315c654248ed61c2485139abad0a7]Branka Palic [clinicaltrials_resource:4810febe6bf5c5a722e8e7430cc78ac9]Branka Palic [clinicaltrials_resource:515811fab1637181319dfdaf2fa26bd0]Branka Palic [clinicaltrials_resource:5cb7090861619e867047fcfe92a50505]Medical Director [clinicaltrials_resource:65bf6ddcb4c627963470f445f630b981]Branka Palic [clinicaltrials_resource:771bd27287a678166bc51766efad9520]Medical Director [clinicaltrials_resource:8d2f17c1c137aec4c2557ce856a5e5a6]Branka Palic [clinicaltrials_resource:9afbd3e96e4e8be71f89d26061adb61e]Medical Director [clinicaltrials_resource:aa7496c16feb61256d4cd33f12d014e5]Medical Affairs [clinicaltrials_resource:ceba5533c1d44fe3782e36b10e160d07]Vice President Medical Affairs [clinicaltrials_resource:e3cb1c6b1a235112b5e87f54948764bf]
affiliation [clinicaltrials_vocabulary:affiliation]
Research Study in Patients With Persistent Macular Edema [clinicaltrials:NCT00035906]A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00363714]clinicaltrials:NCT00554970clinicaltrials:NCT00569192clinicaltrials:NCT00623636clinicaltrials:NCT00627679clinicaltrials:NCT00697697clinicaltrials:NCT00697801clinicaltrials:NCT00995904clinicaltrials:NCT01042678clinicaltrials:NCT01086761clinicaltrials:NCT01089062Safety Study of LiRIS in Interstitial Cystitis (IC) Patients [clinicaltrials:NCT01150565]clinicaltrials:NCT01191723clinicaltrials:NCT01199965clinicaltrials:NCT01468558Safety, Tolerability and Efficacy Study of LiRIS® 400mg in Women With Interstitial Cystitis [clinicaltrials:NCT01824303]A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC)and Hunner's Lesions [clinicaltrials:NCT01879683]
collaborator [clinicaltrials_vocabulary:collaborator]
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome [clinicaltrials:NCT00025818]Research Study in Patients With Persistent Macular Edema [clinicaltrials:NCT00035906]clinicaltrials:NCT00076687Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00141882]A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% [clinicaltrials:NCT00151541]clinicaltrials:NCT00156910clinicaltrials:NCT00168298clinicaltrials:NCT00168324clinicaltrials:NCT00168337Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00168350]Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00168363]clinicaltrials:NCT00168389A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis [clinicaltrials:NCT00168402]A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis [clinicaltrials:NCT00168415]clinicaltrials:NCT00168428A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia [clinicaltrials:NCT00168441]clinicaltrials:NCT00168454A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis [clinicaltrials:NCT00168480]Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency [clinicaltrials:NCT00243542]A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop [clinicaltrials:NCT00243711]A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea. [clinicaltrials:NCT00249782]clinicaltrials:NCT00284518Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00300443]clinicaltrials:NCT00311376AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers [clinicaltrials:NCT00325715]Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332059]Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332072]Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332345]Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332384]Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332436]Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332540]clinicaltrials:NCT00333814A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis [clinicaltrials:NCT00333996]A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash [clinicaltrials:NCT00343187]A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00363714]Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis [clinicaltrials:NCT00380783]Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy [clinicaltrials:NCT00381719]clinicaltrials:NCT00395057clinicaltrials:NCT00432341clinicaltrials:NCT00439140
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome [clinicaltrials:NCT00025818]Research Study in Patients With Persistent Macular Edema [clinicaltrials:NCT00035906]clinicaltrials:NCT00076687Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00141882]A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% [clinicaltrials:NCT00151541]clinicaltrials:NCT00156910clinicaltrials:NCT00168298clinicaltrials:NCT00168324clinicaltrials:NCT00168337Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00168350]Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00168363]clinicaltrials:NCT00168389A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis [clinicaltrials:NCT00168402]A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis [clinicaltrials:NCT00168415]clinicaltrials:NCT00168428A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia [clinicaltrials:NCT00168441]clinicaltrials:NCT00168454A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis [clinicaltrials:NCT00168480]Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency [clinicaltrials:NCT00243542]A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop [clinicaltrials:NCT00243711]A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea. [clinicaltrials:NCT00249782]clinicaltrials:NCT00284518Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00300443]clinicaltrials:NCT00311376AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers [clinicaltrials:NCT00325715]Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332059]Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332072]Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332345]Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332384]Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332436]Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00332540]clinicaltrials:NCT00333814A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis [clinicaltrials:NCT00333996]A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash [clinicaltrials:NCT00343187]A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00363714]Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis [clinicaltrials:NCT00380783]Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy [clinicaltrials:NCT00381719]clinicaltrials:NCT00395057clinicaltrials:NCT00432341clinicaltrials:NCT00439140
source [clinicaltrials_vocabulary:source]
Allergan [clinicaltrials_resource:80124512cb2eba14e3f43e0326e728c2]
Bio2RDF identifier
80124512cb2eba14e3f43e0326e728c2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:80124512cb2eba14e3f43e0326e728c2
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:80124512cb2eba14e3f43e0326e728c2
title
Allergan
@en
type
label
Allergan [clinicaltrials_resource:80124512cb2eba14e3f43e0326e728c2]
@en